RecruitingNCT03445585

Biobank for Cholestatic Liver Diseases.

A Resource of Blood and Other Biospecimens of Patients With Cholestatic Liver Disease and Unaffected Individuals


Sponsor

Mayo Clinic

Enrollment

9,150 participants

Start Date

Jan 1, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary biliary cirrhosis/cholangitis (PBC) and primary sclerosing cholangitis (PSC).


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is building a biobank — a library of biological samples and health data — from patients with rare liver diseases that cause bile to build up in the liver (cholestatic liver diseases), including primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), to help researchers find better treatments. **You may be eligible if...** - You have been diagnosed with PSC (primary sclerosing cholangitis) and are between 18 and 85 years old - OR you have been diagnosed with PBC (primary biliary cholangitis) and are between 18 and 85 years old - You meet standard diagnostic criteria for your condition - You are willing to provide biological samples **You may NOT be eligible if...** - You do not have a confirmed diagnosis of PSC or PBC - You are under 18 or over 85 years old - Certain sample types cannot be collected from you (e.g., bile collection after liver transplant) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03445585


Related Trials